Literature DB >> 25464114

Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture.

Suzanne L Tomchuck1, Wing H Leung2, Mari H Dallas3.   

Abstract

Rate of immune reconstitution directly correlates with the number of hematopoietic stem cells infused and is particularly delayed in patients undergoing cord blood (CB) transplantation (CBT). Methods to increase the number of CB natural killer (NK) cells have the potential to improve immune reconstitution after CBT. NK cells are the first lymphocyte population to recover after hematopoietic stem cells transplantation and are central to preventing early relapse and infection. CB NK cells are low in number and are known to be incomplete in maturation and require activation for effective function. Here, we report a clinically relevant ex vivo expansion method that increases the number of activated CB NK cells. We report a multilog increase in NK cell number when CB mononuclear cells are cocultured with IL-2 and IL-15. Furthermore, NK cells expressing activating receptors and adhesion molecules responsible for cytotoxicity increased throughout culture, whereas inhibitory receptor expression remained low. Additionally, cytotoxic function against various malignancies was significantly enhanced in cultured NK cells but not CD3(+)CD56(+) cells. These data suggest that ex vivo expansion and activation of CB NK cells is a clinically feasible and relevant approach to prevent early infection and relapse after CBT.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cord blood; Cytotoxicity; Ex vivo expansion; Killer cell immunoglobulin-like receptors (KIR); Natural killer

Mesh:

Substances:

Year:  2014        PMID: 25464114      PMCID: PMC4700822          DOI: 10.1016/j.bbmt.2014.10.014

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  33 in total

1.  Phenotypic differences between cord blood and adult peripheral blood.

Authors:  María C López; Brent E Palmer; David A Lawrence
Journal:  Cytometry B Clin Cytom       Date:  2008-07-18       Impact factor: 3.058

Review 2.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

3.  NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Authors:  Andreas T Björklund; Marie Schaffer; Cyril Fauriat; Olle Ringdén; Mats Remberger; Christina Hammarstedt; A John Barrett; Per Ljungman; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
Journal:  Blood       Date:  2010-01-22       Impact factor: 22.113

4.  Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.

Authors:  Dongxia Xing; Alan G Ramsay; John G Gribben; William K Decker; Jared K Burks; Mark Munsell; Sufang Li; Simon N Robinson; Hong Yang; David Steiner; Nina Shah; John D McMannis; Richard E Champlin; Chitra Hosing; Patrick A Zweidler-McKay; Elizabeth J Shpall; Catherine M Bollard
Journal:  J Immunother       Date:  2010-09       Impact factor: 4.456

5.  A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.

Authors:  S Carlens; M Gilljam; B J Chambers; J Aschan; H Guven; H G Ljunggren; B Christensson; M S Dilber
Journal:  Hum Immunol       Date:  2001-10       Impact factor: 2.850

6.  Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study.

Authors:  S R Yoon; Y S Lee; S H Yang; K H Ahn; Je-H Lee; Ju-H Lee; D Y Kim; Y A Kang; M Jeon; M Seol; S G Ryu; J W Chung; I Choi; K H Lee
Journal:  Bone Marrow Transplant       Date:  2009-11-02       Impact factor: 5.483

7.  Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.

Authors:  J Clausen; D Wolf; A L Petzer; E Gunsilius; P Schumacher; B Kircher; G Gastl; D Nachbaur
Journal:  Clin Exp Immunol       Date:  2007-06       Impact factor: 4.330

8.  Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.

Authors:  Hiroyuki Fujisaki; Harumi Kakuda; Noriko Shimasaki; Chihaya Imai; Jing Ma; Timothy Lockey; Paul Eldridge; Wing H Leung; Dario Campana
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

9.  Defining early human NK cell developmental stages in primary and secondary lymphoid tissues.

Authors:  Diana N Eissens; Jan Spanholtz; Arnold van der Meer; Bram van Cranenbroek; Harry Dolstra; Jaap Kwekkeboom; Frank W M B Preijers; Irma Joosten
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

10.  Frozen cord blood hematopoietic stem cells differentiate into higher numbers of functional natural killer cells in vitro than mobilized hematopoietic stem cells or freshly isolated cord blood hematopoietic stem cells.

Authors:  Martha Luevano; Anna Domogala; Michael Blundell; Nicola Jackson; Isabela Pedroza-Pacheco; Sophie Derniame; Michelle Escobedo-Cousin; Sergio Querol; Adrian Thrasher; Alejandro Madrigal; Aurore Saudemont
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

View more
  9 in total

Review 1.  NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?

Authors:  Catharina H M J Van Elssen; Stefan O Ciurea
Journal:  Int J Hematol       Date:  2017-12-01       Impact factor: 2.490

2.  A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation.

Authors:  Li Li; Han Chen; David Marin; Yuanxin Xi; Qi Miao; Jiangxing Lv; Pinaki Prosad Banerjee; Hila Shaim; May Daher; Rafet Basar; Nobuhiko Imahashi; Juan Jimenez; Bingqian Hu; Rohtesh S Mehta; Lucila Nassif Kerbauy; Mecit Kaplan; Mayela Mendt; Gonca Ozcan; Elif Gokdemir; Mayra Hernandez Sanabria; Ye Li; Ken Chen; Jing Wang; Luis Muniz-Feliciano; Wei-Li Zhao; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood Adv       Date:  2019-12-10

Review 3.  Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies.

Authors:  Gianfranco Pittari; Perla Filippini; Giusy Gentilcore; Jean-Charles Grivel; Sergio Rutella
Journal:  Front Immunol       Date:  2015-05-13       Impact factor: 7.561

Review 4.  Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.

Authors:  Anne M Dickinson; Jean Norden; Shuang Li; Ilona Hromadnikova; Christoph Schmid; Helga Schmetzer; Hans Jochem-Kolb
Journal:  Front Immunol       Date:  2017-06-07       Impact factor: 7.561

Review 5.  The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer.

Authors:  Katayoun Rezvani; Rayne H Rouce
Journal:  Front Immunol       Date:  2015-11-17       Impact factor: 7.561

Review 6.  Cord Blood as a Source of Natural Killer Cells.

Authors:  Rohtesh S Mehta; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Front Med (Lausanne)       Date:  2016-01-05

Review 7.  Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.

Authors:  Stanislaw Schmidt; Lars Tramsen; Bushra Rais; Evelyn Ullrich; Thomas Lehrnbecher
Journal:  Oncotarget       Date:  2018-04-17

Review 8.  Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire.

Authors:  Carrie R Willcox; Martin S Davey; Benjamin E Willcox
Journal:  Front Immunol       Date:  2018-07-02       Impact factor: 7.561

Review 9.  Cord-Blood Natural Killer Cell-Based Immunotherapy for Cancer.

Authors:  Xiaoyan Zhao; Li Cai; Yu Hu; Huafang Wang
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.